ADLYXINE
ADLYXINE
Discontinued
DIN Number
02464276
Drug Class
Human
Market Date
Sep 12, 2017
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02464276
AIG Number0159090003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BJ03 LIXISENATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
LIXISENATIDEActive
Strength: 10 MCG / ACT
Monograph: LIXISENATIDE